Liabilities / Assets
34th percentile
Higher debt load relative to assets than 34% of similar nonprofits.
T a G Treatment Action Group Inc.
990 • Fiscal year 2016 • EIN 13-3624785
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.03x
Liabilities / Revenue
34th percentile
Higher debt load relative to revenue than 34% of similar nonprofits.
Net Margin
5th percentile
Higher net margin than 5% of similar nonprofits.
Top Officer Pay
88th percentile
Higher top officer pay than 88% of similar nonprofits.
Top officer pay equals 11.3% of source-year revenue.
Asset Growth
4th percentile
Faster asset growth than 4% of similar nonprofits.
Revenue Growth
12th percentile
Faster revenue growth than 12% of similar nonprofits.
Balance Sheet
Assets
Down$2,592,218
Down $1,017,753 (-28%) from 2015
Net Assets
Down$2,518,135
Down $1,071,102 (-30%) from 2015
Liabilities
Up$74,083
Up $53,349 (+257%) from 2015
Revenue And Expenses
Revenue
Down$1,623,672
Down $607,208 (-27%) from 2015
Expenses
Up$2,690,029
Up $270,835 (+11%) from 2015
Net Income
Down-$1,066,357
Down $878,043 (-466%) from 2015
Historical Trend
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2016 to Dec 31, 2016
- Signed
- Nov 13, 2017
- Return Version
- 2016v3.0
- Gross Receipts
- $1,715,624
Mission and Program Overview
Mission
Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. Tag is science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. Tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.
See schedule o treatment action group, inc. ("tag") is a not-for-profit organization incorporated under the laws of the state of new york. Founded in january 1992, tag is an independent, activist and community-based research and policy think tank fighting for better treatment, prevention, a vaccine, and a cure for hiv, tuberculosis, and hepatitis c virus. Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. We are science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. Tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.the primary sources of revenue to tag are contributions and grants.tag is a nonprofit organization exempt from federal income tax under section 501(c)(3) of the internal revenue code.
Balance Sheet Detail
| Line | Beginning | End | Change |
|---|---|---|---|
| Assets | |||
| Savings and Temporary Cash Investments | $2,961,238 | $1,946,728 | ▼ $1,014,510 |
| Accounts Receivable | $171,984 | $73,871 | ▼ $98,113 |
| Cash and Non-Interest-Bearing Accounts | $10,140 | $31,960 | ▲ $21,820 |
| Prepaid Expenses and Deferred Charges | $24,928 | $31,826 | ▲ $6,898 |
| Land, Buildings, and Equipment, Net | $17,666 | $30,870 | ▲ $13,204 |
| Total Assets | $3,609,971 | $2,592,218 | ▼ $1,017,753 |
| Other Assets Total | $424,015 | $476,963 | ▲ $52,948 |
| Liabilities | |||
| Deferred Revenue | $6,621 | $44,570 | ▲ $37,949 |
| Accounts Payable and Accrued Expenses | $14,113 | $29,513 | ▲ $15,400 |
| Total Liabilities | $20,734 | $74,083 | ▲ $53,349 |
| Net Assets / Fund Balance | |||
| Unrestricted Net Assets | $1,649,386 | $1,355,999 | ▼ $293,387 |
| Temporarily Rstr Net Assets | $1,939,851 | $1,162,136 | ▼ $777,715 |
| Total Net Assets Fund Balance | $3,589,237 | $2,518,135 | ▼ $1,071,102 |
| Total Liabilities and Net Assets / Fund Balance | $3,609,971 | $2,592,218 | ▼ $1,017,753 |
Asset Categories
| Asset | Book Value | Depreciation | Basis |
|---|---|---|---|
| Equipment | $30,870 | $54,240 | $85,110 |
| Other Land Buildings | $0 | $7,102 | $7,102 |
| Other Assets Org | $72,463 | - | - |
Compensation and Service Providers
Employees
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| Mark Harrington | Executive Director | FT | $156,138 | $27,589 | $183,727 |
| Scott W Morgan | Deputy Executive Director | FT | $118,877 | $34,977 | $153,854 |
Board Members and Trustees
| Name | Title |
|---|---|
| Barbara Hughes | President |
| Alby P Maccarone Jr | Director |
| David I Sigal | Director |
| Dick Dadey | Director |
| Frank Bua | Director |
| Jason Osher | Director |
| Jim Aquino | Director |
| Joy Episalla | Director |
| Kevin Goetz | Director |
| Monte Steinman | Director |
| Richard Lynn Phd | Director |
| Robert Monteleone | Director |
| Robert W Lennon | Director |
| Roy M Gulick Mdmph | Director |
| Laura Morrison | Secretary/treasurer |
Revenue and Support
Revenue Composition
- Contributions and Grants
- $1,613,585
- Program Service Revenue
- $0
- Investment Income
- $1,885
- Other Revenue
- $8,202
- All Other Contributions
- $1,390,613
- Change in Net Assets
- $-1,066,357
Noncash Contribution Practices
- Property subject to holding requirements
- No
- Reviewed unusual noncash gifts
- No
- Third parties used for noncash contributions
- No
Noncash Contributions
| Contribution Type | Contribution Count | Reported Amount | Valuation Method |
|---|---|---|---|
| Other Non Cash Contri Table | 3 | $99,221 | Selling Value |
| Works of Art | 1 | $75,000 | Selling Value |
| Total Noncash Contributions | 4 | $174,221 | - |
Audited Revenue Reconciliation
- Revenue per Audited Statements
- $1,623,672
- Revenue Not Reported on Financial Statements
- $0
- Revenue Not Reported on Form 990
- $0
- Total Revenue per Audited Statements
- $1,623,672
- Total Revenue per Form 990
- $1,623,672
Expenses and Functional Allocation
Major Expense Lines
| Line Item | Amount |
|---|---|
| Salaries, Compensation, and Employee Benefits | $1,620,733 |
| Other Expenses | $1,045,190 |
| Total Fundraising Expense | $215,951 |
| Grants and Similar Amounts Paid | $24,106 |
| Professional Fundraising Fees | $0 |
Functional Expense Allocation
| Line Item | Program | Management | Fundraising | Total |
|---|---|---|---|---|
| Other Salaries and Wages | $872,556 | $101,819 | $22,749 | $997,124 |
| Current Officers, Directors, Trustees, and Key Employees | $253,351 | $54,118 | $30,112 | $337,581 |
| Conferences and Meetings | $284,858 | $884 | - | $285,742 |
| Travel | $184,870 | $1,278 | $4,390 | $190,538 |
| Fees for Services Other | $80,653 | $7,261 | $101,156 | $189,070 |
| Other Employee Benefits | $137,028 | $39,179 | $1,934 | $178,141 |
| Occupancy | $131,773 | $4,123 | $3,093 | $138,989 |
| Payroll Taxes | $91,509 | $12,304 | $4,074 | $107,887 |
| Advertising | $55,246 | $3,182 | $23,550 | $81,978 |
| Office Expenses | $35,860 | $25,748 | $5,528 | $67,136 |
| Foreign Grants | $24,106 | - | - | $24,106 |
| Information Technology | $6,870 | $6,752 | $4,167 | $17,789 |
| Fees for Services Accounting | - | $17,500 | - | $17,500 |
| Fees for Services Legal | - | $13,640 | - | $13,640 |
| Insurance | $5,066 | $4,443 | - | $9,509 |
| Depreciation Depletion | - | $7,246 | - | $7,246 |
| Fees for Services Lobbying | $2,486 | - | - | $2,486 |
| Other Expenses | $3,072 | $1,330 | $2,565 | $1,330 |
| Total Functional Expenses | $2,169,304 | $304,774 | $215,951 | $2,690,029 |
Audited Expense Reconciliation
| Line Item | Amount |
|---|---|
| Expenses per Audited Statements | $2,690,029 |
| Total Expenses per Audited Statements | $2,690,029 |
| Total Expenses per Form 990 | $2,690,029 |
| Expenses Not Reported on Financial Statements | $0 |
| Expenses Not Reported on Form 990 | $0 |
International Activity
International Summary
- Offices
- 0
- Employees
- 0
- Spending
- $324,258
International Compliance
- Activity in boycott countries
- No
- Foreign corporation ownership
- No
- Foreign partnership interest
- No
- Interest in foreign trust
- No
- Passive foreign investment company interest
- No
- Transfers to foreign corporations
- No
International Activities
| Region | Activity | Services | Offices | Employees | Spending |
|---|---|---|---|---|---|
| United Kingdom | IUATLD WORLD LUNG HEALTH CONFERENCE OCTOBER, 2016, > LIVERPOOL, ENGLAND, UK | Tb/hiv | 0 | 0 | $90,505 |
| South Africa | International Aids Conference July, 2016 - Durban South Africa | Tb/hiv | 0 | 0 | $72,771 |
| Spain | Afa Conference | Hvc Hepatitis | 0 | 0 | $19,420 |
| Spain | EASL MEETING APRIL, 2016 > BARCELONA, SPAIN | Hcv Antiretrovirals | 0 | 0 | $17,511 |
| South Africa | International Aids Conference July, 2016 - Durban South Africa | Hiv Antiretrovirals | 0 | 0 | $13,094 |
| South Africa | International Aids Conference July, 2016 - Durban South Africa | Hcv Hepatitis | 0 | 0 | $11,350 |
| Spain | HEPCOALITION STRATEGY MEETING FEBRUARY, 2016 > BARCELONA, SPAIN | Hcv Hepatitis | 0 | 0 | $9,510 |
| India | Tb Team India Junket | Tb/hiv | 0 | 0 | $9,056 |
| South Africa | International Aids Conference July, 2016 - Durban South Africa | Bsvc Basic Science Vaccine Cure | 0 | 0 | $8,222 |
| India | (RE: SMALL GRANT TO KETHO) NAGALAND USERS NETWORK INDIA | Tb/hiv | 0 | 0 | $5,882 |
| United Kingdom | Iualtd | Tb/hiv | 0 | 0 | $4,939 |
| South Africa | International Aids Conference July, 2016 - Durban South Africa | Communications | 0 | 0 | $4,743 |
| Norway | Inhsu Conference September 2016 - Oslo, Norway | Hcv Hepatitis | 0 | 0 | $4,657 |
| New Guinea | El Junket August 2016 - Papa, New Guinea | Tb/hiv | 0 | 0 | $4,435 |
| India | Small Grant to Kalinga Network Plwha India | Tb/hiv | 0 | 0 | $4,434 |
| New Guinea | Rglc Mtg Papua New Guinea | Tb/hiv | 0 | 0 | $3,536 |
| South Africa | International Aids Conference July, 2016 - Durban South Africa | Policy | 0 | 0 | $3,253 |
| India | Tb Consultant Ketho Angami Mou Expenses | Tb/hiv | 0 | 0 | $3,150 |
| India | N. LINGASAMY INDIA RE: SMALL GRANT TO MMCF | Tb/hiv | 0 | 0 | $2,860 |
| South Africa | TAC RE: BALANCE MOU 18NOV2015 AS CONSULTANT FOR TB ACTVITIES CAPE TOWN IUATLD | Tb/hiv | 0 | 0 | $2,667 |
| South Africa | International Aids Conference July, 2016 - Durban South Africa | Administration | 0 | 0 | $2,500 |
| Peru | Subgrant | Tb/hiv | 0 | 0 | $2,000 |
| Uganda | Subgrant | Tb/hiv | 0 | 0 | $1,600 |
| United Kingdom | Meera Senthilingam Uk 04/05/16 Balance Fee Write-up Study Dot | Tb/hiv | 0 | 0 | $1,500 |
| Canada | Mcgill Dxrx Course | Tb/hiv | 0 | 0 | $1,499 |
| Switzerland | EL MEETINGS WHO ETC JUNE, 2016 > GENEVA, SWIRTZERLAND | Tb/hiv | 0 | 0 | $1,458 |
| South Africa | IUATLD WORLD LUNG HEALTH CONFERENCE NOVEMBER 2015 > CAPE TOWN, SA | Tb/hiv | 0 | 0 | $1,333 |
| Bulgaria | ANA BALKANDJIEVA BULGARIA RE: ADMIN TB ONLINE WEBSITE AND NEWLETTER | Tb/hiv | 0 | 0 | $1,200 |
| Bulgaria | ANA BALKANDJIEVA BULGARIA RE: ADMIN TB ONLINE WEBSITE AND NEWLETTER > 2ND/FINAL 2016 | Tb/hiv | 0 | 0 | $1,200 |
| Korea | Who Ltbi | Tb/hiv | 0 | 0 | $1,172 |
| Canada | N. LINGASAMY INDIA>MONTREAL MCGILL DXRX COURSE DEPART 06/18//16 | Tb/hiv | 0 | 0 | $1,035 |
| South Africa | Subgrant | Tb/hiv | 0 | 0 | $1,000 |
| United Kingdom | Tac Cape Town Reimburse Airtix M.low and A.thom Re Iuatld Uk | Tb/hiv | 0 | 0 | $966 |
| Indonesia | World Health Assembly | Tb/hiv | 0 | 0 | $910 |
| Canada | Keystone | Tb/hiv | 0 | 0 | $845 |
| Russia | Kk Moscow Junket | Hcv Hepstitis | 0 | 0 | $839 |
| Belgium | Ema Meeting | Tb/hiv | 0 | 0 | $814 |
| Germany | EATG MEETING APRIL, 2016 > BERLIN, GERMANY | Hcv Hepatitis | 0 | 0 | $683 |
| Canada | Keystone Conference | Tb/hiv | 0 | 0 | $575 |
| France | BANK WIRE TO IMAXI FRANCE RE: AIR TRAVEL LUSIANA APRILAWATI TO ATTEND WORLD HEALTH ASSEMBLY | Tb/hiv | 0 | 0 | $545 |
| France | IMAXI FRANCE RE: AIR TRAVEL LUSIANA APRILAWATI TO ATTEND WORLD HEALTH ASSEMBLY | Tb/hiv | 0 | 0 | $545 |
| South Africa | MATTE BOX MEDIA RE: 50% CONTRACT BALANCE AV/VIDEO SERVICES RE: IUATLD CAPE TOWN (C... | Tb/hiv | 0 | 0 | $526 |
| Canada | Tb Union Nar | Tb/hiv | 0 | 0 | $482 |
| Canada | Mcgill Training | Tb/hiv | 0 | 0 | $443 |
| New Zealand | Phn | Tb/hiv | 0 | 0 | $286 |
| Russia | Kk Russia Junket | Hcv Hepatitis | 0 | 0 | $283 |
| Spain | Easl Member Dues | Hvc Hepatitis | 0 | 0 | $210 |
| France | UNION INTERNATIONALE PARIS 02/24 > IUATLD ANNUAL MEMBERSHIP RENEWAL | Tb/hiv | 0 | 0 | $172 |
| Kenya | Tb Law Workshop | Tb/hiv | 0 | 0 | $165 |
| South Africa | Pholokgolo Ramothwala for Proofing Tag Pipeline Report at Durban Printer | Tb/hiv | 0 | 0 | $151 |
| South Africa | MARCUS LOW IN SOUTH AFRICA > HONORARIUM AS WEBINAR MODERATOR | Tb/hiv | 0 | 0 | $150 |
| Switzerland | Bdq Gdc | Tb/hiv | 0 | 0 | $148 |
| United Kingdom | Journal Renewal Jid Oxford Press | Administration | 0 | 0 | $133 |
| United Kingdom | Journal Renewal Cid Oxford Press | Hiv Antiretrovirals | 0 | 0 | $115 |
| Korea | Ltbi | Tb/hiv | 0 | 0 | $112 |
| Switzerland | Who Stag | Tb/hiv | 0 | 0 | $108 |
| United Kingdom | Journal Renewal Jid Oxford Press | Tb/hiv | 0 | 0 | $96 |
| Switzerland | Geneva Who | Tb/hiv | 0 | 0 | $90 |
| United Kingdom | Book From Oxford Press | Tb/hiv | 0 | 0 | $87 |
| Kenya | Human Rights Tb | Tb/hiv | 0 | 0 | $82 |
| Kenya | Kenya Junket | Tb/hiv | 0 | 0 | $53 |
| Korea | Lbti | Tb/hiv | 0 | 0 | $42 |
| South Africa | Union Cab | Tb/hiv | 0 | 0 | $40 |
| Russia | Kk Kiyev Junket | Hcv Hepatitis | 0 | 0 | $33 |
| Norway | Inhsu | Hiv Antiretrovirals | 0 | 0 | $25 |
| Switzerland | Sag | Tb/hiv | 0 | 0 | $12 |
Fundraising, Events, and Gaming
- Fundraising activities
- Yes
- Gaming activities
- No
- Professional fundraiser used
- No
Fundraising and Gaming Totals
| Line Item | Amount |
|---|---|
| Fundraising Direct Expenses | $91,952 |
| Fundraising Gross Income | $71,773 |
| Professional Fundraising Fees | $0 |
Fundraising Events
| Event | Gross Receipts | Gross Revenue | Direct Expenses | Net Income |
|---|---|---|---|---|
| Riaa | $291,470 | $71,773 | - | $71,773 |
| Total Events | $291,470 | $71,773 | $90,552 | $-18,779 |
Political and Lobbying Activity
- Political campaign activity
- No
- Lobbying activity
- Yes
- Subject to proxy tax
- No
Insider Transactions and Loans
Interested-Person Transactions
| Interested Party | Relationship | Description | Shared Revenue | Amount |
|---|---|---|---|---|
| Andrea Benzacar Dailey | Domestic Partner of the Board President | Employment | No | $40,348 |
Governance and Compliance
Governance Checklist
- Compiled or reviewed by an accountant
- No
- Annual disclosure for covered persons
- Yes
- Audit committee
- Yes
- Business relationship with family members
- Yes
- Business relationship with organization members
- No
- Material changes to governing documents
- No
- Compensation from other sources disclosed
- No
- CEO compensation reviewed
- Yes
- Other officer compensation reviewed
- Yes
- Conflict-of-interest policy
- Yes
- Audited financial statements prepared
- No
- Key decisions subject to board approval
- No
- Management duties delegated
- No
Governance Explanations
Form 990, Part VI, Section B, Line 11B
“A draft of form 990 was sent to members of the board of directors for review and approval. The audit committee reviewed the form 990 and reported to the executive committee and the board of trustees before the return was filed with the irs.”
Form 990, Part VI, Section B, Line 12C
“Conflict of interest policy requires board members and key staff to complete an annual disclosure statement. The related individual will be excluded from the discussion and the voting process.”
Form 990, Part VI, Section B, Line 15
“Compensation for key employees is reviewed and approved by the executive director. Compensation for the executive director is reviewed and approved by the board of directors. This was last completed in 2016.”
Form 990, Part VI, Section C, Line 19
“The organization's governing documents are available upon request. Annual reports are available on the organization's website.”
Filing and Contact Details
Filer
- Filer Name
- Treatment Action Group Inc
- EIN
- 13-3624785
- Phone
- 2122537922
- Address
- 90 BROAD STREET NO 2503, NEW YORK, NY 10004
Signing Officer
- Name
- Laura Morrison
- Title
- Secretary/treasurer
- Phone
- 2122537922
- Signed
- 2017-11-13
- Discuss with paid preparer
- Yes
Organization Details
- Principal Officer
- Laura Morrison
- Formed
- 1992
- Legal Domicile
- Ny
- Voting Board Members
- 15
- Independent Board Members
- 15
- Employees
- 18
- Volunteers
- 15
Preparer
- Firm
- Loeb & Troper Llp
- Address
- 655 THIRD AVENUE 12TH FLOOR, NEW YORK, NY 10017
- Preparer
- Aaron Shapiro
- Phone
- 2128674000
Supplemental Narrative
Additional Explanations
FORM 990, PART XII, LINE 2C:
“The process has not changed since the prior year.”
Financial Statement Notes
PART III, LINE 4:
“The art prints are to be given to major donors of the "research in action awards" event.”
PART X, LINE 2:
“Tag has determined that there are no material uncertain tax positions that require recognition or disclosure in the financial statements. Periods ending december 31, 2013 and subsequent remain subject to examination by applicable taxing authorities.”
Raw XML AppendixShowing 400 of 1,061 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990/AccountantCompileOrReviewInd | 0 | 0 |
| IRS990/AccountsPayableAccrExpnssGrp/BOYAmt | 0 | 14113 |
| IRS990/AccountsPayableAccrExpnssGrp/EOYAmt | 0 | 29513 |
| IRS990/AccountsReceivableGrp/BOYAmt | 0 | 171984 |
| IRS990/AccountsReceivableGrp/EOYAmt | 0 | 73871 |
| IRS990/ActivitiesConductedPrtshpInd | 0 | 0 |
| IRS990/ActivityOrMissionDesc | 0 | SEE SCHEDULE O TREATMENT ACTION GROUP, INC. ("TAG") IS A NOT-FOR-PROFIT ORGANIZATION INCORPORATED UNDER THE LAWS OF THE STATE OF NEW YORK. FOUNDED IN JANUARY 1992, TAG IS AN INDEPENDENT, ACTIVIST AND COMMUNITY-BASED RESEARCH AND POLICY THINK TANK FIGHTING FOR BETTER TREATMENT, PREVENTION, A VACCINE, AND A CURE FOR HIV, TUBERCULOSIS, AND HEPATITIS C VIRUS. TAG WORKS TO ENSURE THAT ALL PEOPLE WITH HIV, TB, OR HCV RECEIVE LIFESAVING TREATMENT, CARE, AND INFORMATION. WE ARE SCIENCE-BASED TREATMENT ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS. TAG CATALYZES OPEN COLLECTIVE ACTION BY ALL AFFECTED COMMUNITIES, SCIENTISTS, AND POLICY MAKERS TO END HIV, TB, AND HCV.THE PRIMARY SOURCES OF REVENUE TO TAG ARE CONTRIBUTIONS AND GRANTS.TAG IS A NONPROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. |
| IRS990/AdvertisingGrp/FundraisingAmt | 0 | 23550 |
| IRS990/AdvertisingGrp/ManagementAndGeneralAmt | 0 | 3182 |
| IRS990/AdvertisingGrp/ProgramServicesAmt | 0 | 55246 |
| IRS990/AdvertisingGrp/TotalAmt | 0 | 81978 |
| IRS990/AllOtherContributionsAmt | 0 | 1390613 |
| IRS990/AnnualDisclosureCoveredPrsnInd | 0 | 1 |
| IRS990/AuditCommitteeInd | 0 | 1 |
| IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt | 0 | JOSEPH MCCONNELL |
| IRS990/BooksInCareOfDetail/PhoneNum | 0 | 2122537922 |
| IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 90 BROAD STREET |
| IRS990/BooksInCareOfDetail/USAddress/CityNm | 0 | NEW YORK |
| IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | NY |
| IRS990/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 10004 |
| IRS990/BusinessRlnWithFamMemInd | 0 | 1 |
| IRS990/BusinessRlnWithOfficerEntInd | 0 | 0 |
| IRS990/BusinessRlnWithOrgMemInd | 0 | 0 |
| IRS990/CashNonInterestBearingGrp/BOYAmt | 0 | 10140 |
| IRS990/CashNonInterestBearingGrp/EOYAmt | 0 | 31960 |
| IRS990/ChangeToOrgDocumentsInd | 0 | 0 |
| IRS990/CntrctRcvdGreaterThan100KCnt | 0 | 0 |
| IRS990/CollectionsOfArtInd | 0 | 1 |
| IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt | 0 | 30112 |
| IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt | 0 | 54118 |
| IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt | 0 | 253351 |
| IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt | 0 | 337581 |
| IRS990/CompensationFromOtherSrcsInd | 0 | 0 |
| IRS990/CompensationProcessCEOInd | 0 | 1 |
| IRS990/CompensationProcessOtherInd | 0 | 1 |
| IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt | 0 | 884 |
| IRS990/ConferencesMeetingsGrp/ProgramServicesAmt | 0 | 284858 |
| IRS990/ConferencesMeetingsGrp/TotalAmt | 0 | 285742 |
| IRS990/ConflictOfInterestPolicyInd | 0 | 1 |
| IRS990/ConservationEasementsInd | 0 | 0 |
| IRS990/ConsolidatedAuditFinclStmtInd | 0 | 0 |
| IRS990/ContriRptFundraisingEventAmt | 0 | 222972 |
| IRS990/CreditCounselingInd | 0 | 0 |
| IRS990/CYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/CYContributionsGrantsAmt | 0 | 1613585 |
| IRS990/CYGrantsAndSimilarPaidAmt | 0 | 24106 |
| IRS990/CYInvestmentIncomeAmt | 0 | 1885 |
| IRS990/CYOtherExpensesAmt | 0 | 1045190 |
| IRS990/CYOtherRevenueAmt | 0 | 8202 |
| IRS990/CYProgramServiceRevenueAmt | 0 | 0 |
| IRS990/CYRevenuesLessExpensesAmt | 0 | -1066357 |
| IRS990/CYSalariesCompEmpBnftPaidAmt | 0 | 1620733 |
| IRS990/CYTotalExpensesAmt | 0 | 2690029 |
| IRS990/CYTotalFundraisingExpenseAmt | 0 | 215951 |
| IRS990/CYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/CYTotalRevenueAmt | 0 | 1623672 |
| IRS990/DecisionsSubjectToApprovaInd | 0 | 0 |
| IRS990/DeductibleArtContributionInd | 0 | 1 |
| IRS990/DeductibleNonCashContriInd | 0 | 1 |
| IRS990/DeferredRevenueGrp/BOYAmt | 0 | 6621 |
| IRS990/DeferredRevenueGrp/EOYAmt | 0 | 44570 |
| IRS990/DelegationOfMgmtDutiesInd | 0 | 0 |
| IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt | 0 | 7246 |
| IRS990/DepreciationDepletionGrp/TotalAmt | 0 | 7246 |
| IRS990/Desc | 0 | SEE SCHEDULE OTB/HIV PROJECT:TUBERCULOSIS (TB), THE WORLD'S DEADLIEST INFECTIOUS DISEASE, KILLED 1.7 MILLION PEOPLE IN 2016 (WHO 2017). DESPITE BEING CURABLE, IT IS THE LEADING CAUSE OF DEATH FOR HIV-POSITIVE PEOPLE GLOBALLY. HIV SIGNIFICANTLY INCREASES THE RISK FOR DEVELOPING TB DISEASE. PEOPLE AT RISK FOR BOTH DISEASES REQUIRE TB AND HIV SERVICES THAT WORK TOGETHER. TAG'S TB/HIV PROJECT STRENGTHENS COMMUNITY-DRIVEN ADVOCACY FOR BETTER TB AND TB/HIV RESEARCH, AND HIGH-QUALITY PROGRAMS AND POLICIES WORLDWIDE. THE PROJECT EDUCATES, MOBILIZES, AND EMPOWERS COMMUNITIES TO INCREASE COMMUNITY UNDERSTANDING OF TB/HIV COINFECTION AND TO CATALYZE ACTION TO REDUCE NEW INFECTIONS, DEATHS, AND SUFFERING FROM TB AND TB/HIV. THE PROJECT WORKS WITH RESEARCHERS, COMMUNITY ADVOCATES, POLICY MAKERS, AND GLOBAL COALITIONS TO INCREASE THE QUANTITY AND IMPROVE THE QUALITY OF RESEARCH THAT CAN LEAD TO SHORTER, EASIER TB TREATMENT, MORE ACCURATE DIAGNOSTICS, AND BETTER PREVENTIVE OPTIONS. THE TB/HIV PROJECT CONVENES AND ORGANIZES THE GLOBAL TB COMMUNITY ADVISORY BOARD (TB CAB), A GROUP OF EXPERT, EXPERIENCED COMMUNITY MEMBERS WHO PARTICIPATE ACTIVELY IN ONGOING CONSULTATIONS WITH SPONSORS, FUNDERS, AND ORGANIZERS OF TB PRODUCTS IN DEVELOPMENT, PARTICULARLY NEW TREATMENTS, NEW REGIMENS, AND NEW DIAGNOSTIC TEST PLATFORMS AND ALGORITHMS. THE PROJECT REGULARLY ADVISES AND CONSULTS WITH THE WORLD HEALTH ORGANIZATION (WHO) END TB PROGRAMME, THE STOP TB PARTNERSHIP, UNAIDS, UNITAID, THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA, THE U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC), THE FOOD AND DRUG ADMINISTRATION (FDA), THE NATIONAL INSTITUTES OF HEALTH (NIH) AND PARTICULARLY ITS NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) AND OFFICE OF AIDS RESEARCH, THE OFFICE OF THE GLOBAL AIDS COORDINATOR (OGAC) AND ITS SCIENTIFIC ADVISORY BOARD, USAID, AND TB RESEARCH NETWORKS AND CONSORTIA SUCH AS THE AIDS CLINICAL TRIALS GROUP (ACTG), THE INTERNATIONAL MATERNAL PEDIATRIC AND ADOLESCENT AIDS CLINICAL TRIALS (IMPAACT) NETWORK, THE TB TRIALS CONSORTIUM (TBTC), AND OTHERS ON RESEARCH AGENDA, STUDY DESIGN, IMPLEMENTATION, ANALYSIS, DISSEMINATION OF RESULTS, AND THEIR TRANSLATION INTO POLICIES AND PROGRAMS. |
| IRS990/DescribedInSection501c3Ind | 0 | 1 |
| IRS990/DisregardedEntityInd | 0 | 0 |
| IRS990/DocumentRetentionPolicyInd | 0 | 1 |
| IRS990/DonorAdvisedFundInd | 0 | 0 |
| IRS990/ElectionOfBoardMembersInd | 0 | 0 |
| IRS990/EmployeeCnt | 0 | 18 |
| IRS990/EmploymentTaxReturnsFiledInd | 0 | 1 |
| IRS990/EngagedInExcessBenefitTransInd | 0 | 0 |
| IRS990/ExpenseAmt | 0 | 1155069 |
| IRS990/FamilyOrBusinessRlnInd | 0 | 0 |
| IRS990/FederalGrantAuditRequiredInd | 0 | 0 |
| IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt | 0 | 17500 |
| IRS990/FeesForServicesAccountingGrp/TotalAmt | 0 | 17500 |
| IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt | 0 | 13640 |
| IRS990/FeesForServicesLegalGrp/TotalAmt | 0 | 13640 |
| IRS990/FeesForServicesLobbyingGrp/ProgramServicesAmt | 0 | 2486 |
| IRS990/FeesForServicesLobbyingGrp/TotalAmt | 0 | 2486 |
| IRS990/FeesForServicesOtherGrp/FundraisingAmt | 0 | 101156 |
| IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt | 0 | 7261 |
| IRS990/FeesForServicesOtherGrp/ProgramServicesAmt | 0 | 80653 |
| IRS990/FeesForServicesOtherGrp/TotalAmt | 0 | 189070 |
| IRS990/ForeignActivitiesInd | 0 | 1 |
| IRS990/ForeignFinancialAccountInd | 0 | 0 |
| IRS990/ForeignGrantsGrp/ProgramServicesAmt | 0 | 24106 |
| IRS990/ForeignGrantsGrp/TotalAmt | 0 | 24106 |
| IRS990/ForeignOfficeInd | 0 | 0 |
| IRS990/Form8282PropertyDisposedOfInd | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 0 | 10.50 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 1 | 2.50 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 2 | 0.90 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 3 | 0.20 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 4 | 0.30 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 5 | 0.80 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 6 | 0.10 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 7 | 0.10 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 8 | 0.30 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 9 | 0.10 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 10 | 0.50 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 11 | 1.30 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 12 | 0.60 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 13 | 0.20 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 14 | 0.50 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 15 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 16 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 5 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 6 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 7 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 8 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 9 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 10 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 11 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 12 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 13 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 14 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 7 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 8 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 9 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 10 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 11 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 12 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 13 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 14 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 15 | 27589 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 16 | 34977 |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 0 | BARBARA HUGHES |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 1 | LAURA MORRISON |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 2 | JIM AQUINO |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 3 | FRANK BUA |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 4 | DICK DADEY |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 5 | JOY EPISALLA |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 6 | KEVIN GOETZ |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 7 | ROY M GULICK MDMPH |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 8 | ROBERT W LENNON |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 9 | RICHARD LYNN PHD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 10 | ALBY P MACCARONE JR |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 11 | ROBERT MONTELEONE |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 12 | JASON OSHER |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 13 | DAVID I SIGAL |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 14 | MONTE STEINMAN |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 15 | MARK HARRINGTON |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 16 | SCOTT W MORGAN |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 7 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 8 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 9 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 10 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 11 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 12 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 13 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 14 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 15 | 156138 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 16 | 118877 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 7 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 8 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 9 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 10 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 11 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 12 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 13 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 14 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 15 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 16 | 0 |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 0 | PRESIDENT |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 1 | SECRETARY/TREASURER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 2 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 3 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 4 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 5 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 6 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 7 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 8 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 9 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 10 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 11 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 12 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 13 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 14 | DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 15 | EXECUTIVE DIRECTOR |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 16 | DEPUTY EXECUTIVE DIRECTOR |
| IRS990/Form990ProvidedToGvrnBodyInd | 0 | 1 |
| IRS990/FormationYr | 0 | 1992 |
| IRS990/FormerOfcrEmployeesListedInd | 0 | 0 |
| IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd | 0 | X |
| IRS990/FSAuditedInd | 0 | 1 |
| IRS990/FundraisingActivitiesInd | 0 | 1 |
| IRS990/FundraisingAmt | 0 | 222972 |
| IRS990/FundraisingDirectExpensesAmt | 0 | 91952 |
| IRS990/FundraisingGrossIncomeAmt | 0 | 71773 |
| IRS990/GamingActivitiesInd | 0 | 0 |
| IRS990/GoverningBodyVotingMembersCnt | 0 | 15 |
| IRS990/GrantAmt | 0 | 16606 |
| IRS990/GrantsToIndividualsInd | 0 | 0 |
| IRS990/GrantsToOrganizationsInd | 0 | 0 |
| IRS990/GrantToRelatedPersonInd | 0 | 0 |
| IRS990/GrossReceiptsAmt | 0 | 1715624 |
| IRS990/GroupReturnForAffiliatesInd | 0 | 0 |
| IRS990/IncludeFIN48FootnoteInd | 0 | 1 |
| IRS990/IndependentAuditFinclStmtInd | 0 | 1 |
| IRS990/IndependentVotingMemberCnt | 0 | 15 |
| IRS990/IndivRcvdGreaterThan100KCnt | 0 | 2 |
| IRS990/IndoorTanningServicesInd | 0 | 0 |
| IRS990/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990/InfoInScheduleOPartVIInd | 0 | X |
| IRS990/InfoInScheduleOPartXIIInd | 0 | X |
| IRS990/InformationTechnologyGrp/FundraisingAmt | 0 | 4167 |
| IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt | 0 | 6752 |
| IRS990/InformationTechnologyGrp/ProgramServicesAmt | 0 | 6870 |
| IRS990/InformationTechnologyGrp/TotalAmt | 0 | 17789 |
| IRS990/InsuranceGrp/ManagementAndGeneralAmt | 0 | 4443 |
| IRS990/InsuranceGrp/ProgramServicesAmt | 0 | 5066 |
| IRS990/InsuranceGrp/TotalAmt | 0 | 9509 |
| IRS990/InvestmentIncomeGrp/ExclusionAmt | 0 | 1885 |
| IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt | 0 | 1885 |
| IRS990/InvestmentInJointVentureInd | 0 | 0 |
| IRS990/IRPDocumentCnt | 0 | 11 |
| IRS990/IRPDocumentW2GCnt | 0 | 0 |
| IRS990/LandBldgEquipAccumDeprecAmt | 0 | 61342 |
| IRS990/LandBldgEquipBasisNetGrp/BOYAmt | 0 | 17666 |
| IRS990/LandBldgEquipBasisNetGrp/EOYAmt | 0 | 30870 |
| IRS990/LandBldgEquipCostOrOtherBssAmt | 0 | 92212 |
| IRS990/LegalDomicileStateCd | 0 | NY |
| IRS990/LoanOutstandingInd | 0 | 0 |
| IRS990/LobbyingActivitiesInd | 0 | 1 |
| IRS990/LocalChaptersInd | 0 | 0 |
| IRS990/MaterialDiversionOrMisuseInd | 0 | 0 |
| IRS990/MembersOrStockholdersInd | 0 | 0 |
| IRS990/MethodOfAccountingAccrualInd | 0 | X |
| IRS990/MinutesOfCommitteesInd | 0 | 1 |
| IRS990/MinutesOfGoverningBodyInd | 0 | 1 |
| IRS990/MissionDesc | 0 | TAG WORKS TO ENSURE THAT ALL PEOPLE WITH HIV, TB, OR HCV RECEIVE LIFESAVING TREATMENT, CARE, AND INFORMATION. WE ARE SCIENCE-BASED TREATMENT ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS. TAG CATALYZES OPEN COLLECTIVE ACTION BY ALL AFFECTED COMMUNITIES, SCIENTISTS, AND POLICY MAKERS TO END HIV, TB, AND HCV. |
| IRS990/MoreThan5000KToIndividualsInd | 0 | 1 |
| IRS990/MoreThan5000KToOrgInd | 0 | 1 |
| IRS990/NetAssetsOrFundBalancesBOYAmt | 0 | 3589237 |
| IRS990/NetAssetsOrFundBalancesEOYAmt | 0 | 2518135 |
| IRS990/NetIncmFromFundraisingEvtGrp/ExclusionAmt | 0 | -20179 |
| IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt | 0 | -20179 |
| IRS990/NetUnrelatedBusTxblIncmAmt | 0 | 0 |
| IRS990/NoncashContributionsAmt | 0 | 174221 |
| IRS990/NondeductibleContributionsInd | 0 | 0 |
| IRS990/OccupancyGrp/FundraisingAmt | 0 | 3093 |
| IRS990/OccupancyGrp/ManagementAndGeneralAmt | 0 | 4123 |
| IRS990/OccupancyGrp/ProgramServicesAmt | 0 | 131773 |
| IRS990/OccupancyGrp/TotalAmt | 0 | 138989 |
| IRS990/OfficeExpensesGrp/FundraisingAmt | 0 | 5528 |
| IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt | 0 | 25748 |
| IRS990/OfficeExpensesGrp/ProgramServicesAmt | 0 | 35860 |
| IRS990/OfficeExpensesGrp/TotalAmt | 0 | 67136 |
| IRS990/OfficerMailingAddressInd | 0 | 0 |
| IRS990/OperateHospitalInd | 0 | 0 |
| IRS990/Organization501c3Ind | 0 | X |
| IRS990/OrganizationFollowsSFAS117Ind | 0 | X |
| IRS990/OtherAssetsTotalGrp/BOYAmt | 0 | 424015 |
| IRS990/OtherAssetsTotalGrp/EOYAmt | 0 | 476963 |
| IRS990/OtherChangesInNetAssetsAmt | 0 | -4745 |
| IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt | 0 | 1934 |
| IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt | 0 | 39179 |
| IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt | 0 | 137028 |
| IRS990/OtherEmployeeBenefitsGrp/TotalAmt | 0 | 178141 |
| IRS990/OtherExpensesGrp/Desc | 0 | OTHER |
| IRS990/OtherExpensesGrp/Desc | 1 | MOVING EXPENSES |
| IRS990/OtherExpensesGrp/Desc | 2 | BAD DEBT |
| IRS990/OtherExpensesGrp/FundraisingAmt | 0 | 12633 |
| IRS990/OtherExpensesGrp/FundraisingAmt | 1 | 2565 |
| IRS990/OtherExpensesGrp/ManagementAndGeneralAmt | 0 | 3967 |
| IRS990/OtherExpensesGrp/ManagementAndGeneralAmt | 1 | 1330 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 0 | 3072 |
| IRS990/OtherExpensesGrp/TotalAmt | 0 | 12633 |
| IRS990/OtherExpensesGrp/TotalAmt | 1 | 9604 |
| IRS990/OtherExpensesGrp/TotalAmt | 2 | 1330 |
| IRS990/OtherRevenueMiscGrp/BusinessCd | 0 | 900099 |
| IRS990/OtherRevenueMiscGrp/Desc | 0 | OTHER |
| IRS990/OtherRevenueMiscGrp/ExclusionAmt | 0 | 28381 |
| IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt | 0 | 28381 |
| IRS990/OtherRevenueTotalAmt | 0 | 28381 |
| IRS990/OtherSalariesAndWagesGrp/FundraisingAmt | 0 | 22749 |
| IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt | 0 | 101819 |
| IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt | 0 | 872556 |
| IRS990/OtherSalariesAndWagesGrp/TotalAmt | 0 | 997124 |
| IRS990/PartialLiquidationInd | 0 | 0 |
| IRS990/PayPremiumsPrsnlBnftCntrctInd | 0 | 0 |
| IRS990/PayrollTaxesGrp/FundraisingAmt | 0 | 4074 |
| IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt | 0 | 12304 |
| IRS990/PayrollTaxesGrp/ProgramServicesAmt | 0 | 91509 |
| IRS990/PayrollTaxesGrp/TotalAmt | 0 | 107887 |
| IRS990/PoliticalCampaignActyInd | 0 | 0 |
| IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt | 0 | 24928 |
| IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt | 0 | 31826 |
| IRS990/PrincipalOfficerNm | 0 | LAURA MORRISON |
| IRS990/ProfessionalFundraisingInd | 0 | 0 |
| IRS990/ProgSrvcAccomActy2Grp/Desc | 0 | SEE SCHEDULE OHIV PROJECT:IN 2016, 1.0 MILLION PEOPLE DIED OF HIV. THIS IMMENSE PUBLIC HEALTH FAILURE CAN BE ATTRIBUTED TO A DENSE WEB OF MEDICAL, POLITICAL, AND ECONOMIC PROBLEMS. THE VAST MAJORITY OF THE WORLD'S ESTIMATED 36.7 MILLION HIV-POSITIVE PEOPLE (WHO 2017) LIVE IN POOR COUNTRIES WHERE MANY OBSTACLES PREVENT THE WIDESPREAD DISTRIBUTION OF HIV DRUGS. BUT EVEN THE MOST EFFECTIVE EXISTING DRUGS HAVE MAJOR SHORTCOMINGS, AND HIV-POSITIVE PEOPLE EVERYWHERE NEED BETTER TREATMENT STRATEGIES AND, ULTIMATELY, A CURE-ONE THAT IS SCALABLE, AFFORDABLE, AND CAN BE USED WORLDWIDE TO END THE EPIDEMIC ALONG WITH A SAFE AND EFFECTIVE HIV VACCINE. TAG'S HIV PROJECT REVIEWS THE STATE OF RESEARCH ON ANTI-HIV DRUG DISCOVERY, DEVELOPMENT, DISSEMINATION, AND POSTMARKETING SURVEILLANCE. THE HIV PROJECT ADVOCATES FOR ACCELERATED ACCESS TO TREATMENTS; INNOVATION IN THE DEVELOPMENT OF TREATMENTS THAT ARE ACTIVE AGAINST DRUG-RESISTANT HIV; AND DEVELOPMENT OF HIV TREATMENTS THAT ARE EASIER TO TAKE, LESS TOXIC, OR REPRESENT A MAJOR THERAPEUTIC BREAKTHROUGH SUCH AS A NEW DRUG CLASS. THE PROJECT ADVOCATES FOR BETTER POSTMARKETING RESEARCH ON APPROVED ANTIRETROVIRAL DRUGS TO IMPROVE STANDARDS OF CARE; WORKS ON DOMESTIC AND INTERNATIONAL TREATMENT GUIDELINES; AND EDUCATES AND MOBILIZES POLICY MAKERS, RESEARCHERS, AND THE HIV COMMUNITY ON HIV TREATMENT RESEARCH. TAG'S HIV PROJECT WORKS WITH COMMUNITY MEMBERS, SCIENTISTS, AND POLICY MAKERS TO ENHANCE PUBLIC UNDERSTANDING OF THE SCIENCE OF HIV INFECTION, ADDRESS GAPS IN HIV RESEARCH, CRITIQUE RESEARCH EFFORTS, AND FOSTER CROSS-DISCIPLINARY COLLABORATIONS WITH THE AIM OF ACCELERATING RESEARCH ON HIV PATHOGENESIS AND THE DEVELOPMENT OF EFFECTIVE IMMUNE-BASED THERAPIES AND PREVENTIVE TECHNOLOGIES, WITH A PARTICULAR FOCUS ON RESEARCH ADVOCACY AROUND A CURE FOR HIV.THE HIV PROJECT TRACKS AND ANALYZES RESOURCES DEVOTED TO HIV PREVENTION AND COMBINED PREVENTION TECHNOLOGIES. THE PROJECT ADVOCATES FOR LOCAL, STATE, AND NATIONAL AGENCIES AND AIDS SERVICE ORGANIZATIONS TO HAVE INCREASED AWARENESS OF CURRENT PREVENTION TOOLS IN ORDER TO STOP TRANSMISSION OF HIV AND THUS END THE EPIDEMIC. PROJECT MEMBERS WORKED ON GOVERNOR CUOMO'S TASK FORCE TO END AIDS IN NEW YORK STATE BY 2020. THIS EFFORT IS PART OF A BROADER PROJECT BY COMMUNITY ACTIVISTS, POLICY MAKERS, ADVOCATES, AND RESEARCHERS TO END THE EPIDEMIC BY STEMMING NEW INFECTIONS AND ENSURING THAT HIV-POSITIVE PEOPLE RECEIVE CARE, ARE RETAINED IN ACTIVE CARE, AND REMAIN VIRALLY SUPPRESSED. TAG'S HIV PROJECT HAS BEEN LOOKING AT A COHORT OF CASE STUDIES ON BEST PRACTICES IN COMMUNITY MOBILIZATION AND HOW THEY AFFECT THE TREATMENT AND CARE OF BOTH PEOPLE WITH HIV AND THOSE WHO ARE HIV-NEGATIVE.FINALLY, THE HIV PROJECT WORKS WITH GLOBAL AND DOMESTIC PARTNERS FOR UNIVERSAL ACCESS TO HIGH-QUALITY HIV PREVENTION, TREATMENT, AND CARE PROGRAMS. |
| IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt | 0 | 508856 |
| IRS990/ProgSrvcAccomActy2Grp/GrantAmt | 0 | 7500 |
| IRS990/ProgSrvcAccomActy3Grp/Desc | 0 | SEE SCHEDULE OHEPATITIS C- WHO ESTIMATES 71 MILLION PEOPLE ARE LIVING WITH CHRONIC HEPATIS C VIRUS (HCV) INFECTION AND APPROXIMATELY 400,000 PEOPLE DIE EACH YEAR FROM HCV. HIV WORSENS HCV DISEASE PROGRESSION AND OUTCOMES. TAG'S HEPATITIS/HIV PROJECT REVIEWS THE STATE OF RESEARCH ON HCV MONOINFECTION AND COINFECTION. IT ADVOCATES FOR BETTER AND SAFER TREATMENTS, BETTER CLINICAL TRIAL DESIGNS, AND ACCESS TO CURATIVE TREATMENT FOR ALL AFFECTED COMMUNITIES, AND IT CONTINUALLY MONITORS STANDARDS OF CARE FOR PEOPLE WITH HCV MONOINFECTION AND COINFECTION. THE PROJECT WORKS IN COLLABORATION WITH THE HCV AND HIV COMMUNITIES, SCIENTISTS, GOVERNMENT, AND DRUG COMPANIES TO PROVIDE LIFESAVING INFORMATION AND SAFER, MORE TOLERABLE, AND CURATIVE HEPATITIS TREATMENTS UNIVERSALLY AVAILABLE. |
| IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt | 0 | 345198 |
| IRS990/ProgSrvcAccomActyOtherGrp/Desc | 0 | CURE PROJECT:TAG'S BASIC SCIENCE, VACCINES, AND CURE (BSVC) PROJECT BRINGS TOGETHER BASIC AND CLINICAL SCIENTISTS, GOVERNMENT OFFICIALS, REGULATORS, RESEARCHERS, AND COMMUNITY ADVOCATES TO INCREASE FUNDING FOR AND ATTENTION TO BASIC AND CLINICAL SCIENCE THAT WILL LEAD TO AN HIV CURE. THE PURSUIT OF A CURE FOR HIV INFECTION IS NOW A CENTRAL ELEMENT OF THE RESEARCH EFFORT, A TESTAMENT TO THE REMARKABLE SCIENTIFIC PROGRESS THAT HAS OCCURRED OVER THE PAST THREE DECADES. ACHIEVING A CURE IS OF CRITICAL IMPORTANCE FOR HIV-POSITIVE PEOPLE AND FOR REALIZING THE GOAL OF ULTIMATELY ENDING THE PANDEMIC. TAG CONTINUES TO EXPAND OUR ADVOCACY AND EDUCATION WORK RELATED TO HIV CURE RESEARCH ON SEVERAL FRONTS:PROVISION OF RESOURCES AND EDUCATIONAL MATERIALS VIA THE TAG WEBSITE AND SOCIAL MEDIA. RESOURCES INCLUDE: A REGULARLY UPDATED LISTING OF CURE RESEARCH-RELATED CLINICAL TRIALS AND OBSERVATIONAL STUDIES THAT HAS BECOME A WIDELY USED REFERENCE. THE BSVC PROJECT BLOG AND TWITTER FEED, WHICH REPORTS AND COMMENTS ON NEW DEVELOPMENTS IN THE FIELD, INCLUDING PUBLISHED SCIENTIFIC PAPERS AND CONFERENCE PRESENTATIONS. TAG'S CURE RESEARCH MEDIA MONITOR PAGE, WHICH PROVIDES BACKGROUND, CONTEXT AND COMMENTARY ON HIGH PROFILE BUT POTENTIALLY MISLEADING MAINSTREAM NEWS STORIES ON CURE RESEARCH - A BURGEONING PROBLEM AS THE RESEARCH ATTRACTS MORE PUBLICITY. CURE RESEARCH FACT SHEET. COMMUNITY GUIDELINES ON THE USE OF ANTIRETROVIRAL TREATMENT INTERRUPTIONS IN CURE RESEARCH. THE RESEARCH TOWARD A CURE AND IMMUNE-BASED AND GENE THERAPIES CHAPTER OF TAG'S ANNUAL PIPELINE REPORT. LINKS TO KEY ARTICLES AND INFORMATION ON CURE RESEARCH, INCLUDING COMMUNITY-BASED NEWS SOURCES AND OPEN ACCESS SCIENTIFIC PUBLICATIONS.PROVIDING COMMUNITY INPUT INTO CURE RESEARCH PROCESSES, DRAWING ON TAG'S LONG HISTORY AS A LEADER IN HIV RESEARCH ADVOCACY. TAG PARTICIPATES IN MULTIPLE COLLABORATIVE PROJECTS, INCLUDING: THE INTERNATIONAL AIDS SOCIETY (IAS) TOWARDS AN HIV CURE INTERNATIONAL SCIENTIFIC WORKING GROUP, WHICH IS CURRENTLY UPDATING THE IAS TOWARDS AN HIV CURE GLOBAL STRATEGY RECOMMENDATIONS FOR RELEASE AT THE INTERNATIONAL AIDS CONFERENCE IN DURBAN IN 2016. THE FORUM FOR COLLABORATIVE HIV RESEARCH HIV CURE PROJECT, WHICH IS WORKING TO ADDRESS THE REGULATORY CHALLENGES INVOLVED IN CURE RESEARCH. THE COMMUNITY ADVISORY BOARDS (CABS) FOR THE MARTIN DELANEY COLLABORATORYS, WHICH CURRENTLY CONSIST OF THREE LARGE COLLABORATIONS FOCUSED ON HIV CURE RESEARCH (FUNDED PRIMARILY BY THE US NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES). TAG'S BSVC PROJECT DIRECTOR RICHARD JEFFERYS IS A MEMBER OF THE DARE COLLABORATORY CAB AND THE NATIONAL CAB WHICH CONSISTS OF REPRESENTATIVES FROM EACH INDIVIDUAL COLLABORATORY CAB (DARE, CARE AND DEFEATHIV). THE NATIONAL CAB IS CURRENTLY PROVIDING RECOMMENDATIONS FOR FACILITATING COMMUNITY INPUT INTO THE NEXT ROUND OF MARTIN DELANEY COLLABORATORY GRANTS, WHICH WILL BE FUNDED IN 2016. THE RESEARCH WORKING GROUP OF THE FEDERAL AIDS POLICY PARTNERSHIP, WHICH FOCUSES ON INCREASING SUPPORT FOR SCIENTIFIC RESEARCH AND ADDRESSING THE RECENT DECLINE IN FUNDING (IN REAL TERMS) FOR THE NATIONAL INSTITUTES OF HEALTH. TAG'S BSVC PROJECT DIRECTOR RICHARD JEFFERYS IS A MEMBER OF AMFAR'S CURE COUNCIL, WHICH PROVIDES OVERSIGHT OF AMFAR'S EXTENSIVE FUNDING SUPPORT FOR CURE RESEARCH. MEMBERSHIP OF THE STEERING COMMITTEE FOR THE CURRICULUM PROJECT, A COLLABORATIVE ENDEAVOR OF AVAC, THE MARTIN DELANEY COLLABORATORYS, NAPWHA AUSTRALIA, PROJECT INFORM AND SIDACTION. THE CURRICULUM COMPRISES EDUCATIONAL MODULES ON KEY TOPICS IN HIV CURE RESEARCH, WITH TAG CONTRIBUTING MODULES ON THERAPEUTIC VACCINES/IMMUNE-BASED THERAPIES AND BASIC SCIENCE, AND PRESENTING ON THESE CURRICULUM WEBINARS. |
| IRS990/ProgSrvcAccomActyOtherGrp/Desc | 1 | U.S. AND GLOABAL HEALTH POLICY PROJECT.CROSS-PROJECT FUNCTIONS (COMMUNICATIONS AND ADVOCACY, U.S. AND GLOBAL HEALTH POLICY PROJECT)TAG ADVOCATES FOR INCREASED GLOBAL, MULTILATERAL, AND U.S. GOVERNMENT FUNDING FOR RESEARCH AND DEVELOPMENT THAT CAN LEAD TO BETTER AND MORE ACCESSIBLE PREVENTION, DIAGNOSIS, TREATMENT, OR VACCINES FOR HIV/AIDS, HCV, AND TB. TAG PROJECTS WORK IN COLLABORATION WITH GLOBAL AND DOMESTIC HEALTH COALITIONS TO ENSURE EFFECTIVE GLOBAL HIV/AIDS, HCV, AND TB PROGRAMS. TAG WORKS WITH GLOBAL HEALTH ADVOCATES AND ACTIVISTS IN OTHER DONOR AND DEVELOPING COUNTRIES TO PROMOTE AND ADVANCE A COMMON AGENDA OF UNIVERSAL ACCESS TO HIGH-QUALITY, AFFORDABLE, AND EQUITABLE HEALTH CARE SERVICES. EACH TAG PROJECT CREATES AND PUBLISHES NEWSLETTERS, PROJECT-SPECIFIC PUBLICATIONS, BRIEFS, PRESENTATIONS, OR TOOLKITS THAT CAN BE USED FOR THE PURPOSES OF EDUCATION, ADVOCACY, COALITION BUILDING, AND ADVANCING RESEARCH. TAG'S FLAGSHIP PUBLICATION, THE PIPELINE REPORT, ANNUALLY DOCUMENTS AND CRITIQUES THE STATE OF CURRENT TREATMENTS AND THE DEVELOPMENT OF NEW TREATMENTS, VACCINES, AND DIAGNOSTICS FOR THE DISEASE AREAS COVERED BY TAG'S PROJECTS. SINCE 1994, TAG HAS ALSO REGULARLY PUBLISHED ITS COMMUNITY-BASED TREATMENT ADVOCACY MAGAZINE, TAGLINE, PROVIDING DONORS, RESEARCHERS, ADVOCATES, AND PEOPLE WITH HIV, HCV, AND TB WITH ESSENTIAL NEWS, ANALYSIS, AND ORGANIZING INFORMATION REGARDING RELEVANT ISSUES OF POLICY AND SCIENCE. TAG'S WEBSITE PROVIDES ACCESS TO ALL TAG PUBLICATIONS, FREE OF CHARGE, FOR DOWNLOAD ANYWHERE IN THE WORLD. THE WEBSITE INCLUDES PROJECT UPDATES AS WELL AS INFORMATION ON RELEVANT EVENTS AND CONFERENCES, PRESS RELEASES, PAST NEWSLETTERS, ANNUAL REPORTS, AND ANALYSES OF DEVELOPMENTS IN TAG'S PROJECT AREAS.TAG EDUCATES COMMUNITIES, ALLIES, POLICYMAKERS, RESEARCHERS, AND MEDIA AFFECTED BY OR WITH INTEREST IN OR OVERSIGHT OVER HIV, HCV, AND TB AROUND THE UNITED STATES AND THROUGHOUT THE WORLD ABOUT THE LATEST DEVELOPMENTS IN RESEARCH, PREVENTION, AND TREATMENT. TAG ALSO TRAINS AND MENTORS LEADERS OF COMMUNITY-BASED ORGANIZATIONS AND NETWORKS TO STRENGTHEN THEIR ADVOCACY AND SCIENTIFIC LITERACY AROUND HIV, HCV, AND TB. TAG WORKS WITH INDIVIDUALS AND ORGANIZATIONS WORLDWIDE TO SPUR THE DEVELOPMENT OF MORE EFFECTIVE GLOBAL INTERVENTIONS AGAINST HIV, HCV, AND TB AND TO STRENGTHEN TREATMENT EDUCATION AND LITERACY EFFORTS IN DEVELOPED AND DEVELOPING COUNTRIES.IN 2016 AND 2015, EXPENSES FOR THE COMMUNICATIONS AND ADVOCACY PROGRAM WERE ALLOCATED AMONG ALL OTHER PROGRAMS. |
| IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt | 0 | 144777 |
| IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt | 1 | 15404 |
| IRS990/ProhibitedTaxShelterTransInd | 0 | 0 |
| IRS990/PYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/PYContributionsGrantsAmt | 0 | 2259459 |
| IRS990/PYExcessBenefitTransInd | 0 | 0 |
| IRS990/PYGrantsAndSimilarPaidAmt | 0 | 33217 |
| IRS990/PYInvestmentIncomeAmt | 0 | 2096 |
| IRS990/PYOtherExpensesAmt | 0 | 818586 |
| IRS990/PYOtherRevenueAmt | 0 | -30675 |
| IRS990/PYProgramServiceRevenueAmt | 0 | 0 |
| IRS990/PYRevenuesLessExpensesAmt | 0 | -188314 |
| IRS990/PYSalariesCompEmpBnftPaidAmt | 0 | 1567391 |
| IRS990/PYTotalExpensesAmt | 0 | 2419194 |
| IRS990/PYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/PYTotalRevenueAmt | 0 | 2230880 |
| IRS990/QuidProQuoContributionsInd | 0 | 1 |
| IRS990/QuidProQuoContriDisclInd | 0 | 1 |
| IRS990/RcvFndsToPayPrsnlBnftCntrctInd | 0 | 0 |
| IRS990/ReconcilationRevenueExpnssAmt | 0 | -1066357 |
| IRS990/RegularMonitoringEnfrcInd | 0 | 1 |
| IRS990/RelatedEntityInd | 0 | 0 |
| IRS990/RelatedOrganizationCtrlEntInd | 0 | 0 |
| IRS990/ReportInvestmentsOtherSecInd | 0 | 0 |
| IRS990/ReportLandBuildingEquipmentInd | 0 | 1 |
| IRS990/ReportOtherAssetsInd | 0 | 1 |
| IRS990/ReportOtherLiabilitiesInd | 0 | 0 |
| IRS990/ReportProgramRelatedInvstInd | 0 | 0 |
| IRS990/SavingsAndTempCashInvstGrp/BOYAmt | 0 | 2961238 |
| IRS990/SavingsAndTempCashInvstGrp/EOYAmt | 0 | 1946728 |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt | 0 | HONORARIA INCOME AND TRAVEL REIMBURSEMENT |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc | 0 | SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt | 0 | 1611085 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt | 0 | 2294240 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 4468799 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 1490224 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 2112847 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt | 0 | 11977195 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt | 0 | 1885 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt | 0 | 2096 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 2457 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 2815 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 4687 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt | 0 | 13940 |
| IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearAmt | 0 | 28381 |
| IRS990ScheduleA/OtherIncome170Grp/TotalAmt | 0 | 28381 |
| IRS990ScheduleA/PublicOrganization170Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY170Pct | 0 | 0.53210 |
| IRS990ScheduleA/PublicSupportPY170Pct | 0 | 0.51150 |
| IRS990ScheduleA/PublicSupportTotal170Amt | 0 | 6395946 |
| IRS990ScheduleA/SubstantialContributorsTotAmt | 0 | 5581249 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind | 0 | X |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt | 0 | 1611085 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt | 0 | 2294240 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 4468799 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 1490224 |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 2112847 |
| IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt | 0 | 11977195 |
| IRS990ScheduleA/TotalSupportAmt | 0 | 12019516 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990/ScheduleBRequiredInd | 0 | 1 |
| IRS990ScheduleC/DirectContactLegislatorsAmt | 0 | 2486 |
| IRS990ScheduleC/DirectContactLegislatorsInd | 0 | 1 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2016 • Form 990Detailed filing. Detailed filing data is available for this year.
- Assets
- $2,592,218
- Liabilities
- $74,083
- Net assets
- $2,518,135
- Revenue
- $1,623,672
- Expenses
- $2,690,029
- Net income
- -$1,066,357